4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0000921895-25-002765
10% owner sold 4,787,331 shares at $17.75 ($84,975,125)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pontifax Management 4 G.P. (2015) Ltd. 10% owner | 2025-10-15 | Sale | −2,284,612 | $17.75 | $40,551,863 | 0 | I |
| Pontifax Management 4 G.P. (2015) Ltd. 10% owner | 2025-10-15 | Sale | −1,121,045 | $17.75 | $19,898,549 | 0 | I |
| Pontifax Management 4 G.P. (2015) Ltd. 10% owner | 2025-10-15 | Sale | −1,226,412 | $17.75 | $21,768,813 | 0 | I |
| Pontifax Management 4 G.P. (2015) Ltd. 10% owner | 2025-10-15 | Sale | −155,262 | $17.75 | $2,755,901 | 0 | I |
| Open-market sales · 4,787,331 sh · avg $17.75 · $84,975,125 | |||||||
Loading xslF345X05/form414601002_10172025.xml…